Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 10
Submit an article Journal homepage
1,617
Views
0
CrossRef citations to date
0
Altmetric
Commentary

A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand

Punnee Pitisuttithuma Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3215-2183
ORCID Icon &
Ponthip Wirachwongb Research and Development Institute, Government Pharmaceutical Organization, Bangkok, Thailand
Pages 2440-2445 | Received 25 Apr 2019, Accepted 22 Jun 2019, Published online: 05 Sep 2019

References

  • WHO. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2018. Geneva, Switzerland: WHO/GIP; 2018.
  • WHO. Global pandemic influenza action plan to increase vaccine supply. Geneva, Switzerland: WHO; 2006.
  • Iamsirithaworn S, Akarasewi P, Yingyong T, Suthachana S, Pittayawonganon C, Ungchusak K. Three waves of the 2009 H1N1 influenza pandemic in Thailand. Siriraj Med J. 2011;63:64–67.
  • The National Committee on Avian Influenza Control. National Strategic Plan for Avian Influenza Control and Influenza Pandemic Preparedness in Thailand. 2005–2007. Bangkok, Thailand: The Ministry of Public Health; 2005.
  • Executive Committee for Prevention and Control of Avian Influenza and Preparedness for Influenza Pandemic. The second national strategic plan for prevention and control of avian influenza and preparedness for influenza pandemic. Bangkok, Thailand: The Ministry of Public Health; 2008.
  • Sasaki S, Holmes TH, Albrecht RA, Garcia-Sastre A, Dekker CL, He XS, Greenberg HB. Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines. J Infect Dis. 2014;210:865–74. doi:10.1093/infdis/jiu190.
  • Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986;23:66–72.
  • Phonrat B, Pitisuttithum P, Chamnanchanunt S, Puthavathana P, Ngaosuwankul N, Louisirirotchanakul S, Dhitavat J, Thirapakpoomanunt S, Chokevivat V, Wibulpolprasert S. Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais. Vaccine. 2013;31:1503–09. doi:10.1016/j.vaccine.2012.12.082.
  • Surichan S, Wirachwong P, Supachaturas W, Utid K, Theerasurakarn S, Langsanam P, Lakornrach P, Nitisaporn L, Chansikkakorn C, Vangkanonta W, et al. Development of influenza vaccine production capacity by the government pharmaceutical organization of Thailand: addressing the threat of an influenza pandemic. Vaccine. 2011;29(Suppl 1):A29–A33. doi:10.1016/j.vaccine.2011.04.120.
  • Pitisuttithum P, Boonnak K, Chamnanchanunt S, Puthavathana P, Luvira V, Lerdsamran H, Kaewkungwal J, Lawpoolsri S, Thanachartwet V, Silachamroon U, et al. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017;17:833–42. doi:10.1016/S1473-3099(17)30240-2.
  • KR T, CJ L, Khurana S, Manischewitz J, LR K, BA M, RA K, KD L, Qin J, DA F, et al. A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response. J Infect Dis. 2014;209:1860–69. doi:10.1093/infdis/jiu123.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.